Assessment of Distal Limbs Fractures With Cone-Beam CT Newtom 5G
Launched by HOSPICES CIVILS DE LYON · Feb 19, 2013
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient age 18 years old or above, weight ≤ 160 Kg
- • Patient require MDCT for a suspected distal limb fracture or a preoperative assessment
- • French spoken an read
- • Free and informed consent signed
- • Being affiliated to a French social security system or similar.
- Exclusion Criteria:
- • Patients already included in the study for a previous fracture
- • Patient with severe pain and reduced spontaneous mobility that could prevent proper positioning for the cone-beam
- • Lack of effective contraception (risk of pregnancy) or pregnancy proven data on interrogations
- • Patient on protection of the court, under supervision or trusteeship
- • Inability to express a consent
- • Patients already enrolled in a study with a conflict of interest with this study.
- • The presence of osteosynthesis materiel or capital may interfere with image quality. A sample of 3 to 5 patients may be included at the beginning of the study to test the image quality in presence of material.
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Trial Officials
Jean-Baptiste PIALAT, MD,PHD
Principal Investigator
Hospices Civils de Lyon- Hôpital Edouard Herriot
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials